{"id":"W4411295871","doi":"10.1002/art.43272","title":"A Randomized, Double‐Blind, Placebo‐Controlled Trial of Abatacept for the Treatment of Relapsing, Nonsevere Granulomatosis With Polyangiitis","year":2025,"lang":"en","type":"article","venue":"Arthritis & Rheumatology","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; University of Calgary; St. Joseph’s Healthcare Hamilton; University of British Columbia; Mount Sinai Hospital; University of Toronto; St. Paul's Hospital; McMaster University","funders":"National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Cleveland Clinic; University of Toronto; National Institutes of Health; Rare Diseases Clinical Research Network; University of Alberta; Bristol-Myers Squibb; University of South Florida; National Center for Research Resources; University of Pennsylvania; McMaster University; University of Pittsburgh","keywords":"Granulomatosis with polyangiitis; Medicine; Abatacept; Double blind; Randomized controlled trial; Placebo; Dermatology; Internal medicine; Vasculitis; Pathology; Alternative medicine; Disease; Rituximab","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002217975,0.001792078,0.003434802,0.0005430806,0.0007328466,0.0009743886,0.001024912,0.002391703,0.008428545],"category_scores_gemma":[0.002454353,0.0009329782,0.001377773,0.0003796346,0.001682726,0.001006854,0.0003979393,0.002327262,0.001272955],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005235239,"about_ca_system_score_gemma":0.001380507,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007449119,"about_ca_topic_score_gemma":0.00117191,"domain_scores_codex":[0.9988673,0.0006195164,0.00008379423,0.0002118192,0.00008436602,0.0001331961],"domain_scores_gemma":[0.9986047,0.0004394921,0.0003286333,0.0001167781,0.00009766316,0.0004126984],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9852616,0.005606478,0.0002064211,0.0002968857,0.0003399134,0.00002211841,0.00001937658,0.0000867767,0.001718324,0.0000616348,0.0003063271,0.006074123],"study_design_scores_gemma":[0.9802639,0.01902441,0.0002778006,0.000008916737,0.00007803971,0.00000983612,0.000003618983,0.00008864572,0.0001024247,0.00002597044,0.0001130905,0.000003262056],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9826795,0.004060327,0.000936348,0.000781927,0.001334605,0.007281352,0.0008591496,0.0001736993,0.001893209],"genre_scores_gemma":[0.9776813,0.002484479,0.002434324,0.001534682,0.001124202,0.01097248,0.000885865,0.00002803172,0.002854626],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008428545,"threshold_uncertainty_score":0.02819628,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01131484671247945,"score_gpt":0.2729767504237278,"score_spread":0.2616619037112484,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}